Debu Tripathy M.D.'s Books
-
Breast Cancer: Beyond ConventionToday, more breast cancer treatment options are available than ever before. But how can you determine the course of action that is right for YOU? ...Read More
Displaying 1 of
Authors on the Web
Daily Rx, May 7, 2013
...Metastatic HER2 breast cancer patients treated with trastuzumab plus hormone therapy surviving longer (dailyRx News) HER2-postive breast cancers are more aggressive forms of breast cancer. These tumors contain a protein that promotes cancer cell...
PRWeb, May 7, 2013
...treatment of metastatic breast cancer (MBC) patients significantly increased overall survival times. A team of researchers lead by Debu Tripathy, M.D., of the University of Southern California (USC) Norris Comprehensive Cancer Center in Los Angeles, CA,...
BioSpace, May 7, 2013
...treatment of metastatic breast cancer (MBC) patients significantly increased overall survival times. A team of researchers lead by Debu Tripathy, M.D., of the University of Southern California (USC) Norris Comprehensive Cancer Center in Los Angeles,...
BizWire Express, May 7, 2013
...treatment of metastatic breast cancer (MBC) patients significantly increased overall survival times. A team of researchers lead by Debu Tripathy, M.D., of the University of Southern California (USC) Norris Comprehensive Cancer Center in Los Angeles,...
Digital Journal, May 7, 2013
...treatment of metastatic breast cancer (MBC) patients significantly increased overall survival times. A team of researchers lead by Debu Tripathy, M.D., of the University of Southern California (USC) Norris Comprehensive Cancer Center in Los Angeles, CA,...
PRWeb, May 7, 2013
...treatment of metastatic breast cancer (MBC) patients significantly increased overall survival times. A team of researchers lead by Debu Tripathy, M.D., of the University of Southern California (USC) Norris Comprehensive Cancer Center in Los Angeles, CA,...
Bio-Medicine, May 7, 2013
...treatment of metastatic breast cancer (MBC) patients significantly increased overall survival times. A team of researchers lead by Debu Tripathy, M.D., of the University of Southern California (USC) Norris Comprehensive Cancer Center in Los Angeles, CA,...
